Sign Up Today and Learn More About Candid Stock
Invest in or calculate the value of your shares in Candid or other pre-IPO companies through EquityZen's platform.
About Candid Stock
Founded
2014
Headquarters
New York, NY, US
Total Funding
76.3M
Industries
Software, Data and Analytics, Artificial Intelligence
Candid helps people get the smile they've always wanted at a price they can afford. Customers complete an at-home impression kit, and in a matter of weeks, Candid Co sends them custom clear aligners in the mail. In an average of just 5 months, our customers will straighten and whiten their teeth to perfection. Candid Co's network of professional orthodontists oversees the entire treatment process from planning to evaluation to manufacturing. And the best part? It's all without ever having to set foot in a dentist office.
Candid Press Mentions
Stay in the know about the latest news on Candid
Dr. David Little and Dr. John Flucke Join CandidPro's World-class Faculty
prnewswire • Feb 05, 2024
Fluxx Announces Integration with Demographics via Candid to Foster Data-driven Equity in Grantmaking
prnewswire • Nov 21, 2023
Dama to Acquire Candid AI Platform, Continuing to Build Full Suite of Integrated SaaS Solutions for the Cannabis Industry
prnewswire • Oct 24, 2023
GivingData Collaborates with Candid to Advance Equitable Funding Practices
prnewswire • Oct 20, 2023
Murdock Trust’s Romanita Hairston joins Candid Board of Trustees
prweb • Jul 25, 2023
Investors in Candid
Discover investors in Candid stock and explore their portfolio companies
Candid Management
Leadership team at Candid
Co-Founder & Chief Executive Officer
Nick Greenfield
Co-Founder
Bobby Ghoshal
Join now and verify your accreditation status to gain access to:
- Candid current valuation
- Candid stock price
- Available deals in Candid and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Candid stock?
Accredited investors can buy pre-IPO stock in companies like Candid through EquityZen funds. These investments are made available by existing Candid shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Candid stock?
Shareholders can sell their Candid stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
